Linda Sullivan’s article “Standardized Metrics for RBM” is now featured in Applied Clinical Trials’ new 5th edition eBook Risk-Based Monitoring in Clinical Trials: A Focus on Quality Risk Assessment, Management and Planning. The article which focuses on the adoption of standardized cost and quality performance metrics to track and predict performance is featured among several other articles by various authorities in the field of clinical trials that together address questions such as:
- Have the roles of the monitor advanced?
- How are CRAs accepting the change?
- How is pharma implementing RBM—is it more remote, centralized or a combination?
- How important is eSource to RBM?